Stockscreener 앱 받기
402.90
0.10%
-0.40
시간 외 거래:
402.90
Vertex Pharmaceuticals Inc 주식(VRTX)의 최신 뉴스
Vertex to Announce Third Quarter 2025 Financial Results on November 3rd - Business Wire
Former Vertex COO named chief executive at Dravet-focused biotech - The Business Journals
Is Vertex Pharmaceuticals a Smart Investment After Recent FDA Approval for Sickle Cell Therapy? - simplywall.st
What Makes Vertex Pharmaceuticals (VRTX) an Investment Bet? - Yahoo
Vertex Pharmaceuticals: Strong Growth Potential with Promising Product Launches and Robust Pipeline - TipRanks
Cullinan Associates Inc. Sells 1,100 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Will Vertex Pharmaceuticals Incorporated price bounce be sustainableJuly 2025 Momentum & AI Enhanced Execution Alerts - newser.com
Published on: 2025-10-06 04:49:48 - newser.com
DAVENPORT & Co LLC Grows Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Global Assets Advisory LLC Sells 1,124 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
QRG Capital Management Inc. Raises Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Why Vertex Pharmaceuticals Incorporated (VX1) stock remains top ratedQuarterly Portfolio Summary & Weekly High Return Stock Opportunities - newser.com
Is Vertex Pharmaceuticals Incorporated reversing from oversold territoryWeekly Trade Report & Precise Swing Trade Entry Alerts - newser.com
Will Vertex Pharmaceuticals Incorporated (VX1) stock outperform value peersMarket Volume Report & Free High Accuracy Swing Entry Alerts - newser.com
Vertex Pharmaceuticals (VRTX) Highlights Pipeline Progress at BofA Global Healthcare Conference - MSN
2 Beaten-Down Stocks Primed for a Comeback - The Motley Fool
Chart based exit strategy for Vertex Pharmaceuticals IncorporatedMarket Rally & Daily Stock Trend Watchlist - newser.com
News impact scoring models applied to Vertex Pharmaceuticals IncorporatedQuarterly Investment Review & Weekly Watchlist of Top Performers - newser.com
Boston Common Asset Management LLC Has $20.51 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Can Vertex Pharmaceuticals Incorporated stock resist sector downturnsTrade Entry Summary & Breakout Confirmation Trade Signals - newser.com
Strid Group LLC Takes Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Why Vertex Pharmaceuticals Incorporated (VX1) stock could outperform next year2025 Technical Overview & Reliable Breakout Forecasts - newser.com
Ascent Group LLC Sells 790 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
AMF Tjanstepension AB Increases Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
J. Safra Sarasin Holding AG Has $1.34 Million Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
NHS England to Offer Alyftrek for Cystic Fibrosis - respiratory-therapy.com
Insider Sell: Jonathan Biller Sells Shares of Vertex Pharmaceuticals Inc (VRTX) - GuruFocus
Vertex Pharmaceuticals (VRTX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
ServiceNow, Vertex Pharmaceuticals And More: CNBC's 'Final Trades' - Benzinga
With Emma Walmsley exiting GSK, who will be pharma’s top women CEOs? - PharmaVoice
Vertex Pharmaceuticals (VRTX): Assessing Valuation as Shares Hold Steady and Long-Term Prospects Remain Key - Yahoo Finance
Is Vertex Pharmaceuticals Incorporated (VX1) stock overpriced at current multiplesJuly 2025 Update & Free Long-Term Investment Growth Plans - newser.com
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Greenwood Capital Associates LLC - MarketBeat
Why Vertex Pharmaceuticals Incorporated (VX1) stock signals breakout potentialTrade Exit Summary & Low Risk Profit Maximizing Plans - newser.com
Mirae Asset Global Investments Co. Ltd. Acquires 1,270 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Pure Financial Advisors LLC Raises Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
What MACD signals say about Vertex Pharmaceuticals IncorporatedJuly 2025 Pullbacks & Low Volatility Stock Suggestions - newser.com
Published on: 2025-10-03 02:22:36 - newser.com
Published on: 2025-10-03 01:57:58 - newser.com
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
Vertex Pharmaceuticals (VRTX) Receives Raised Price Target from Citigroup | VRTX Stock News - GuruFocus
Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price Expected to Rise, Citigroup Analyst Says - MarketBeat
CHURCHILL MANAGEMENT Corp Sells 4,392 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Janney Montgomery Scott LLC Buys 3,271 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Diabetic Peripheral Neuropathy Market Expected to Experience Major Growth by 2034, According to DelveInsight | Grünenthal, Averitas Pharma, Daiichi Sankyo, Vertex Pharma, Helixmith, Lexicon Pharma - Barchart.com
Published on: 2025-10-01 09:22:12 - newser.com
What Does the Market Think About Vertex Pharmaceuticals Inc? - Sahm
Lbp Am Sa Has $17.52 Million Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Cooper Financial Group - MarketBeat
2.42%
0.19%
자본화:
|
볼륨(24시간):